Looks at how people in medullary thyroid cancer studies stay in or leave
Observes whether adults with medullary thyroid cancer finish clinical trials.
Plain-language title generated from the registry record
Registry title: A Detailed Look At What Patients Experience In Medullary Thyroid Cancer Clinical Study
Key facts
- Where
- San Francisco, United StatesSee the site
Where in United States
- Power Life SciencesSan Francisco, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Power Life Sciences Inc.
- Trial code
- NCT06079723
- Record updated
- 12 October 2023
- Original description
Clinical studies, with a distinct emphasis on medullary thyroid cancer, play a pivotal role in evaluating the safety and effectiveness of novel treatments for this condition. These trials serve as essential tools to determine whether new medications surpass conventional therapies, providing substantial evidence to endorse their broader adoption.Read full original descriptionShow less
Analyzing the Patterns of Patient Engagement and Trends in Participation Observed in Medullary Thyroid Cancer Clinical Trials
Clinical studies, with a distinct emphasis on medullary thyroid cancer, play a pivotal role in evaluating the safety and effectiveness of novel treatments for this condition. These trials serve as essential tools to determine whether new medications surpass conventional therapies, providing substantial evidence to endorse their broader adoption.
The primary objective is to meticulously examine trial completion rates and voluntary withdrawals within this specific patient group. By actively participating in this observational study plays a critical role in pushing medical knowledge forward and advancing care for individuals suffering from the medullary thyroid cancer.
Inclusion: Confirmed diagnosis of medullary thyroid cancer; Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed; No serious medical or psychiatric illness likely to interfere with participation in this clinical study.
Exclusion: Patients who are currently receiving any other investigational drug; Any serious and/or unstable pre-existing medical disorders; Is pregnant, breastfeeding or expecting to conceive within the projected duration of the study.